Comparative Dosimetric Evaluation of Volumetric-Modulated Arc Therapy (VMAT) Versus Intensity-Modulated Radiotherapy (IMRT) in Thoracic Esophageal Cancer

Document Type : Original Paper


1 Department of Physics, Tilak Dhari P. G. College, Jaunpur, (U.P.) - 222002, INDIA and Department of Radiation Oncology, Lecturer(Physicist), Uttar Pradesh University of Medical Sciences, Saifai etawah-UP 206130 India

2 Department of Physics, Tilak Dhari P. G. College, Jaunpur, (U.P.) - 222002, INDIA

3 Department of Radiation Oncology, Uttar Pradesh University of Medical Sciences, Saifai, Etawah (U.P.) - 206130, INDIA

4 Department of Radiation Oncology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Vibhuti Khand Gomti Nagar, Lucknow -226010

5 Department of Radiation Oncology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Vibhuti Khand Gomti Nagar, Lucknow -226010 India


Introduction: With the introduction of Intensity Modulated Radiotherapy (IMRT) approach, better dosimetry results and patient outcomes has been attained for various anatomical sites. In present study, a comparative dosimetric evaluation of Volumetric-Modulated Arc Therapy (VMAT) versus two techniques of IMRT i.e. Dynamic IMRT (d-IMRT) and step & shoot IMRT (ss-IMRT) was done for thoracic esophageal cancer.
Material and Methods: VMAT, ss-IMRT, and d-IMRT plans were generated on the Computed Tomography Simulator data sets of 13 Patients with thoracic esophageal carcinoma who had been treated earlier. The prescription dose for each patient was 50.4 Gy in 28 fractions. All the plans were optimized to achieve greater or equal to 95% of the prescribed dose to the Planning Target Volume (PTV). Dose to PTV and organ at risk (OAR) were compared with the help of Dose Volume Histogram (DVH).
Results: VMAT and d-IMRT plans were nearly equivalent for PTV coverage, homogeneity index (HI), and uniformity index (UI) (p> 0.05). However, VMAT and d-IMRT plans had superior PTV coverage, HI, and UI, (p < 0.01) than ss-IMRT. For PTV, the Dmean, D98, and D95 values in ss-IMRT were significantly less than VMAT and d-IMRT (p< 0.05).
Conclusion: All three techniques are able to provide a homogeneous and conformal dose distribution. VMAT offers better homogeneous dose distribution and may be preferred for treating thoracic esophageal carcinoma. Thus, the multi-arc VMAT technique may be a better option with equivalent or superior dose distribution, uniformity, and homogeneity.


Main Subjects

  1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2021 May;71(3):209-49.
  2. Phukan RK, Ali MS, Chetia CK, Mahanta J. Betel nut and tobacco chewing; potential risk factors of cancer of oesophagus in Assam, India: British Journal of Cancer. 2001 Sep 1;85(5):661–
  3. Rochet N, Kieser M, Sterzing F, Krause S, Lindel K, Harms W, et al. Phase II study evaluating consolidation whole abdominal intensity-modulated radiotherapy (IMRT) in patients with advanced ovarian cancer stage FIGO III - The OVAR-IMRT-02 Study. BMC Cancer. 2011 Jan 28;11.
  4. Dirix P, Vanstraelen B, Jorissen M, vander Poorten V, Nuyts S. Intensity-modulated radiotherapy for sinonasal cancer: Improved outcome compared to conventional radiotherapy. International Journal of Radiation Oncology Biology Physics. 2010 Nov 15;78(4):998-1004.
  5. Orlandi E, Palazzi M, Pignoli E, Fallai C, Giostra A, Olmi P. Radiobiological basis and clinical results of the simultaneous integrated boost (SIB) in intensity modulated radiotherapy (IMRT) for head and neck cancer: a review. Critical reviews in oncology/hematology. 2010 Feb 1;73(2):111-25.
  6. Staffurth J. A review of the clinical evidence for intensity-modulated radiotherapy. Clinical oncology. 2010 Oct 1;22(8):643-57.
  7. Pederson AW, Fricano J, Correa D, Pelizzari CA, Liauw SL. Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: an exploration of dose–volume histogram parameters to limit genitourinary and gastrointestinal toxicity. International Journal of Radiation Oncology* Biology* Physics. 2012 Jan 1;82(1):235-41.
  8. Yu CX. Intensity-modulated arc therapy with dynamic multileaf collimation: an alternative to tomotherapy. Physics in Medicine & Biology. 1995 Sep 1;40(9):1435.
  9. Van Benthuysen L, Hales L, Podgorsak MB. Volumetric modulated arc therapy vs. IMRT for the treatment of distal esophageal cancer. Medical Dosimetry. 2011 Dec 1;36(4):404-9.
  10. Guo XQ, Mao RH, Liu B, Ge H. Study on esophageal cancer radiotherapy dosimetry and position verification for volumetric modulated arc therapy. Asian Journal of Surgery. 2023 Jan 1;46(1):120-5.
  11. Duan Y, Liu X, Liu Z, Zhan N, Zhu Z, Deng Z. Dosimetric and Efficiency Comparisons between Volumetric Modulated Arc Therapy and IMRT for Cervical-Thoracic Esophageal Cancers. Journal of Cancer Therapy. 2021 Nov 1;12(11):593-601.
  12. Zhou Y, Xiang X, Xiong J, Gong C. Comprehensive comparison of progressive optimization algorithm based automatic plan and manually planned treatment technique for cervical-thoracic esophageal cancers. Technology in Cancer Research & Treatment. 2020 Nov 11;19:1533033820973283.
  13. Lin JC, Tsai JT, Chang CC, Jen YM, Li MH, Liu WH. Comparing treatment plan in all locations of esophageal cancer: Volumetric modulated arc therapy versus intensity-modulated radiotherapy. Medicine (United States). 2015 May 1;94(17):e750.
  14. Zhang N, Gu M, Wang J, Wu S. Comparison of nodal irradiation dose using radiotherapy for patients with thoracic esophageal cancer. Oncology Letters. 2020;19(1):1042–
  15. Kataria T, Govardhan HB, Gupta D, Mohanraj U, Bisht SS, Sambasivaselli R, Goyal S, Abhishek A, Srivatsava A, Pushpan L, Kumar V. Dosimetric comparison between Volumetric Modulated Arc Therapy (VMAT) vs Intensity Modulated Radiation Therapy (IMRT) for radiotherapy of mid esophageal carcinoma. Journal of Cancer Research and Therapeutics. 2014 Oct 1;10(4):871-7.
  16. Shao Y, Chen H, Wang H, Duan Y, Feng A, Huang Y, Gu H, Kong Q, Xu Z. Investigation of predictors to achieve acceptable lung dose in T-shaped upper and middle esophageal cancer with IMRT and VMAT. Frontiers in Oncology. 2021 Oct 7;11:735062.
  17. Cozzi L, Dinshaw KA, Shrivastava SK, Mahantshetty U, Engineer R, Deshpande DD, Jamema SV, Vanetti E, Clivio A, Nicolini G, Fogliata A. A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. Radiotherapy and oncology. 2008 Nov 1;89(2):180-91.
  18. Singh HB, Gandhi AK, Sapru S, Khurana R, Hadi R, Nanda SS, Rath S, Bharati A, Srivastava AK, Mishra SP, Sahni K. Comparison of Volumetric Modulated Arc Therapy and Three-Dimensional Conformal Radiotherapy in Postoperative High-Grade Glioma: A Dosimetric Comparison. Iranian Journal of Medical Physics. 2019 Sep 1;16(5):385-91.
  19. Wolff D, Stieler F, Welzel G, Lorenz F, Abo-Madyan Y, Mai S, Herskind C, Polednik M, Steil V, Wenz F, Lohr F. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiotherapy and oncology. 2009 Nov 1;93(2):226-33.
  20. Mayo CS, Ding L, Addesa A, Kadish S, Fitzgerald TJ, Moser R. Initial experience with volumetric IMRT (RapidArc) for intracranial stereotactic radiosurgery. International Journal of Radiation Oncology Biology Physics. 2010 Dec 1;78(5):1457–
  21. Suntharalingam M, Winter K, Ilson D, Dicker AP, Kachnic L, Konski A, et al. Effect of the addition of cetuximab to paclitaxel, cisplatin, and radiation therapy for patients with esophageal cancer the NRG oncology rtog 0436 phase 3 randomized clinical trial. JAMA Oncology. 2017 Nov 1;3(11):1520–
  22. Feuvret L, Noël G, Mazeron JJ, Bey P. Conformity index: a review. International Journal of Radiation Oncology* Biology* Physics. 2006 Feb 1;64(2):333-42.
  23. Menzel HG. The international commission on radiation units and measurements. J ICRU. 2010;10(1):1–
  24. McIntosh A, Read PW, Khandelwal SR, Arthur DW, Turner AB, Ruchala KJ, Olivera GH, Jeswani S, Sheng K. Evaluation of coplanar partial left breast irradiation using tomotherapy-based topotherapy. International Journal of Radiation Oncology* Biology* Physics. 2008 Jun 1;71(2):603-10.
  25. Sheng K, Molloy JA, Larner JM, Read PW. A dosimetric comparison of non-coplanar IMRT versus Helical Tomotherapy for nasal cavity and paranasal sinus cancer. Radiotherapy and oncology. 2007 Feb 1;82(2):174-8.
  26. Chandra A, Guerrero TM, Liu HH, Tucker SL, Liao Z, Wang X, Murshed H, Bonnen MD, Garg AK, Stevens CW, Chang JY. Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer. Radiotherapy and Oncology. 2005 Dec 1;77(3):247-53.
  27. Bedford JL, Viviers L, Guzel Z, Childs PJ, Webb S, Tait DM. A quantitative treatment planning study evaluating the potential of dose escalation in conformal radiotherapy of the oesophagus. Radiotherapy and Oncology. 2000 Nov 1;57(2):183-93.
  28. Chen YJ, Liu A, Han C, Tsai PT, Schultheiss TE, Pezner RD, Vora N, Lim D, Shibata S, Kernstine KH, Wong JY. Helical tomotherapy for radiotherapy in esophageal cancer: a preferred plan with better conformal target coverage and more homogeneous dose distribution. Medical Dosimetry. 2007 Sep 1;32(3):166-71.
  29. Martin S, Chen JZ, Dar AR, Yartsev S. Dosimetric comparison of helical tomotherapy, RapidArc, and a novel IMRT & Arc technique for esophageal carcinoma. Radiotherapy and Oncology. 2011 Dec 1;101(3):431-7.
  30. Lin CY, Huang WY, Jen YM, Chen CM, Su YF, Chao HL, Lin CS. Dosimetric and efficiency comparison of high-dose radiotherapy for esophageal cancer: volumetric modulated arc therapy versus fixed-field intensity-modulated radiotherapy. Diseases of the Esophagus. 2014 Aug 1;27(6):585-90.
  31. Nicolini G, Ghosh-Laskar S, Shrivastava SK, Banerjee S, Chaudhary S, Agarwal JP, Munshi A, Clivio A, Fogliata A, Mancosu P, Vanetti E. Volumetric modulation arc radiotherapy with flattening filter-free beams compared with static gantry IMRT and 3D conformal radiotherapy for advanced esophageal cancer: a feasibility study. International Journal of Radiation Oncology* Biology* Physics. 2012 Oct 1;84(2):553-60.
  32. Yin L, Wu H, Gong J, Geng JH, Jiang F, Shi AH, Yu R, Li YH, Han SK, Xu B, Zhu GY. Volumetric-modulated arc therapy vs c-IMRT in esophageal cancer: A treatment planning comparison. World journal of gastroenterology: WJG. 2012 Oct 10;18(37):5266.
  33. Xu C, Xi M, Komaki R, Balter PA, Huang M, Hobbs BP, Wang L, Lin SH. Dosimetric and clinical outcomes after volumetric modulated arc therapy for carcinoma of the thoracic esophagus. Advances in Radiation Oncology. 2017 Jul 1;2(3):325-32.
  34. Zhang Y, Wang H, Huang X, Zhang Q, Ren R, Sun R, et al. Dosimetric comparison of TomoDirect, helical tomotherapy, VMAT, and ff-IMRT for upper thoracic esophageal carcinoma. Medical Dosimetry. 2019 Jun 1;44(2):167–
  35. Marks LB, Bentzen SM, Deasy JO, Bradley JD, Vogelius IS, El Naqa I, and et al. Radiation dose–volume effects in the lung. International Journal of Radiation Oncology* Biology* Physics. 2010 Mar 1;76(3):S70-6.
  36. Hsu CX, Lin KH, Wang SY, Tsai WT, Chang CH, Tien HJ, Shueng PW, Wu TH, Mok GS. Planning evaluation of a novel volume-based algorithm for personalized optimization of lung dose in VMAT for esophageal cancer. Scientific reports. 2022 Feb 15;12(1):2513.
  37. Wei X, Liu HH, Tucker SL, Wang S, Mohan R, Cox JD, Komaki R, Liao Z. Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy. International Journal of Radiation Oncology* Biology* Physics. 2008 Mar 1;70(3):707-14.